Identification of T cell and linear B cell epitopes on African horse sickness virus serotype 4 proteins VP1-1, VP2, VP4, VP7 and NS3

Vaccine. 2024 Jan 12;42(2):136-145. doi: 10.1016/j.vaccine.2023.12.028. Epub 2023 Dec 14.

Abstract

The viral proteins VP1-1, VP2, VP4, VP7 and NS3, of African horse sickness virus serotype 4 (AHSV4), have previously been identified to contain CD8+ T cell epitopes. In this study, overlapping peptides spanning the entire sequences of these AHSV4 proteins were synthesized and used to map epitopes. Peripheral blood mononuclear cells (PBMC) isolated from five horses immunized with an attenuated AHSV4 were stimulated in vitro with the synthesized peptides. Various memory immune assays were used to identify the individual peptides that contain CD8+ T cell epitopes, CD4+ T cell epitopes and linear B cell epitopes. The newly discovered individual peptides of AHSV4 proteins VP1-1, VP4, VP7 and/or NS3 that contain CD8+ T cell, CD4+ T cell or linear B cell epitopes could contribute to the design and development of new generation AHS peptide-based vaccines and therapeutics.

Keywords: Conserved epitopes; Linear B cell epitopes; New generation AHS peptide-based vaccines; Overlapping synthetic peptides; T cell epitopes.

MeSH terms

  • African Horse Sickness Virus*
  • African Horse Sickness*
  • Animals
  • Capsid Proteins
  • Epitopes, B-Lymphocyte
  • Epitopes, T-Lymphocyte
  • Horses
  • Leukocytes, Mononuclear
  • Peptides
  • Serogroup

Substances

  • Epitopes, B-Lymphocyte
  • Epitopes, T-Lymphocyte
  • Capsid Proteins
  • Peptides